Mesoblast Limited

MEOBF ·Healthcare, Drug Manufacturers - General, Australia
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2021

Total Assets: $744.7M

Liabilities Breakdown FY2021

Total Liabilities: $163.3M